Metraipolis › archive › dc_f175e4fed9ed
Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41178590
- DOI
- 10.1080/07853890.2025.2581812
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:50:17.624Z
- SHA-256 of the archived text
40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2- Stable URL of this page
https://metraipolis.com/documento/dc_f175e4fed9ed
How to cite
Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590 — Europe PMC (en), https://europepmc.org/article/MED/41178590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f175e4fed9ed (Metraipolis archive dc_f175e4fed9ed, sha256 40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2)
BibTeX
@misc{dcf175e4fed9ed,
title = {Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience — Europe PMC PMID:41178590},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41178590},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f175e4fed9ed; sha256 40484fa533974febce27299d533da8dc9668383f1498aad2d6abab70e73021d2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41178590. Agents can read the archived copy with the MCP tool read_document.